Your institution may have access to this item. Find your institution then sign in to continue.
Title
News updates.
Abstract
Reports that Cephalon Inc. has submitted a treatment investigational New Drug Application to the Food and Drug Administration for myotrophin. Use of the drug in the treatment of amyotrophic lateral sclerosis or Lou Gehrig's disease.